Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 15c
Tweet
Share
E-mailGet Alerts ELDN Hot Sheet
Join SI Premium – FREE
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.75), $0.15 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- HomeTrust Bancshares, Inc. (HTB) Tops Q2 EPS by 7c
- Knowles (KN) Tops Q2 EPS by 2c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
